2.24 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Organogenesis Holdings Inc. Class A Common Stock
ORGONASDAQ • USD
2.23
↗ 0.14 (6.38%)
POST MARKET (AS OF 06:32 PM EDT)
Post Market
AS OF 06:32 PM EDT
2.23
↗ 0.14 (6.38%)
Market: OPEN
Open?$2.27
High?$2.37
Low?$2.23
Prev. Close?$2.24
Volume?1.3M
Avg. Volume?708.9K
VWAP?$2.29
Rel. Volume?1.77x
Bid / Ask
Bid?$1.96 × 100
Ask?$2.58 × 100
Spread?$0.62
Midpoint?$2.27
Valuation & Ratios
Market Cap?288.2M
Shares Out?128.6M
Float?99.4M
Float %?78.3%
P/E Ratio?18.18
P/B Ratio?0.96
EPS?$0.12
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.59Strong
Quick Ratio?3.29Strong
Cash Ratio?0.94Adequate
Debt/Equity?0.17Low
ValuationATTRACTIVELY VALUED
Score93/100
P/E?18.2FAIR▾
P/B?0.96CHEAP▾
P/S?0.51CHEAP▾
P/FCF?N/A▾
EV/EBITDA?3.3CHEAP▾
EV/Sales?0.43CHEAP▾
Returns & Efficiency
ROE?5.3%FAIR▾
ROA?2.7%WEAK▾
Cash Flow & Enterprise
FCF?$-24460000
Enterprise Value?$244.9M
Related Companies
Loading...
News
Profile
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Employees
854
Market Cap
288.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2016-11-29
Address
85 DAN ROAD
CANTON, MA 02021
Phone: 781-575-0775
CANTON, MA 02021
Phone: 781-575-0775